Bahraini adults with type-2 diabetes on SGLT2 inhibitors generally have better blood sugar control and lost more weight over 32 weeks than patients who were not taking them, a recent study has shown.The study titled ‘Efficacy of SGLT2 Inhibitors Among Adult Bahraini Patients Attending Central Diabetic Clinics: A Real-World Retrospective Observational Study’ looked at whether diabetes medicine could help Bahraini adults with type 2 diabetes control their blood sugar levels and lose weight .
